Formidable Asset Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Formidable Asset Management, LLC

  • $609 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$7.37 - $13.61 $3.47 Million - $6.4 Million
-470,419 Closed
0 $0
Q4 2020

Jan 29, 2021
SELL
$3.37 - $8.61 $363,221 - $927,994
-107,781 Reduced 18.64%
470,419 $3.47 Million
Q3 2020

Nov 13, 2020
SELL
$3.43 - $5.53 $74,774 - $120,554
-21,800 Reduced 3.63%
578,200 $1.95 Million
Q2 2020

Aug 13, 2020
BUY
$1.9 - $5.61 $1.14 Million - $3.37 Million
600,000 New
600,000 $3.14 Million

Others Institutions Holding BCRX

# of Institutions
281
Shares Held
171M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.42B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email